Skip to main navigation Skip to search Skip to main content

Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population

  • Hiroaki Kasashima
  • , Angeles Duran
  • , Anxo Martinez-Ordoñez
  • , Yuki Nakanishi
  • , Hiroto Kinoshita
  • , Juan F. Linares
  • , Miguel Reina-Campos
  • , Yotaro Kudo
  • , Antoine L'Hermitte
  • , Masakazu Yashiro
  • , Masaichi Ohira
  • , Fei Bao
  • , Daniele V.F. Tauriello
  • , Eduard Batlle
  • , Maria T. Diaz-Meco*
  • , Jorge Moscat*
  • *Corresponding author for this work
  • Sanford Burnham Prebys Medical Discovery Institute
  • Cornell University
  • Osaka Metropolitan University
  • Scripps Clinic
  • Institute for Research in Biomedicine
  • Radboud University Medical Center
  • ICREA
  • Centro de Investigación Biomédica en Red (CIBER)

Research output: Contribution to journal › Article › Academic › peer-review

105 Citations (Scopus)

Abstract

Kasashima et al. describe a molecular mechanism whereby the loss of PKCζ in the stroma upregulates SOX2 to activate the reprogramming of colonic fibroblasts generating a SFRP1/2-expressing CAF population. This population supports epithelial tumor progression, revealing vulnerabilities in mesenchymal CMS4 colorectal cancer.

Original languageEnglish
Pages (from-to)95-110.e10
JournalDevelopmental Cell
Volume56
Issue number1
DOIs
Publication statusPublished - 11 Jan 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population'. Together they form a unique fingerprint.

Cite this